MedStar Health Joins NESTcc Research Network

The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), has welcomed MedStar Health as the newest network collaborator to join the NESTcc Research Network.

“MedStar Health is pleased to join as a NESTcc Network Collaborator, and we look forward to our exciting and important work together,” said Neil J. Weissman, M.D., FACC, FASE, chief scientific officer for MedStar Health and president of MedStar Health Research Institute. “Our partnership with NESTcc will allow us to utilize our clinical research expertise to advance health using real-world evidence from the delivery of care, as well as expand the scale of our impact for patients and clinicians.”
 
NESTcc’s research network of internationally recognized health organizations supports the generation of real-world evidence and collaboration with stakeholders across the medical device ecosystem. In partnership with its network collaborators, NESTcc curates diverse data sources and research expertise, applying rigorous methodologies and data standards to enable efficient, high-quality studies of medical devices. Studies have been developed across multiple disease areas, device classes in the U.S. Food and Drug Administration 510(k) and premarket approval (PMA) pathways and all stages of the total product life cycle. NESTcc recently opened access to its research network for sponsored studies.
 
Leveraging access to electronic health records, claims, and other relevant data from 4.2 million unique patients across MedStar Health’s 10 hospitals and 300 service centers, MedStar Health Research Institute is the executive research organization for MedStar Health, headquartered in Maryland. The Research Institute provides scientific research infrastructure and administrative and regulatory support for programs conducted at MedStar Health facilities. From bench to bedside to community, MedStar Health plans and conducts studies that advance medical knowledge and translate research into improved patient care. With more than 300 active investigators, research areas of focus include cardiovascular, health care delivery, cancer, neuroscience and rehabilitation, diabetes, women and infant service and orthopedics and sports medicine.
 
“NESTcc continues to transform the paradigm of clinical research, expanding access to high-quality evidence and informing clinical and regulatory decision-making to empower people with safe and effective technologies,” said Sandra Siami, MPH, senior vice president, NESTcc, MDIC. “Our growing research network is helping NESTcc set the standard for real-world evidence innovation, and MedStar Health’s diversity of data and caliber of investigators will make them a key partner and driver of excellence for us and our research sponsors.”
 
With the addition of MedStar Health, the NESTcc Research Network is now comprised of 16 network collaborators with access to data from more than 161 million patients.